{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T01:39:00Z","timestamp":1788745140305,"version":"build-2803163510"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Hepatitis C virus (HCV) infection remains a major cause of liver related morbidity and mortality worldwide. Epidemiologic data on seroprevalence, viremia prevalence and risk factors remain limited in sub-Saharan Africa. In Ghana, HCV-related deaths are estimated to have increased since 2015. Risk factors associated with HCV infection in Ghana are not well described. The aim of this study was to determine the prevalence of, and risk factors associated with hepatitis C virus infection in the Upper East Region located in the northern part of Ghana. A community-based cross-sectional study was conducted in 9 communities in the Upper East region of Ghana. A total of 1,769 participants aged \u226512 years were screened for HCV antibody (anti-HCV) using rapid diagnostic testing (RDT). Seventy-four participants undertook HCV RNA testing after a positive anti-HCV result. Multivariate logistic regression was used to determine risk factors associated with HCV seropositivity. The anti-HCV prevalence was 8.4%, with 149 out of 1,769 testing anti-HCV positive. Mean age (\u00b1SD) of seropositive persons was 45.4 (\u00b116.3) years. The highest anti-HCV seroprevalence was amongst persons aged 60 years and above. Forty-four out of 74 (59.5%) seropositive cases had viremic infection and the estimated viremic prevalence in the screened population was 5.0%. Predictors of HCV seropositivity were age (OR 1.03 95% CI 1.01\u20131.04), history of female genital mutilation or circumcision (OR 1.63 95% CI 1.04\u20132.55), sexual activity (OR 2.57 95% CI 1.38\u20134.79), positive maternal HCV status (OR 10.38 95% CI 4.13\u201326.05) and positive HIV status (OR 4.03 95% CI 1.35\u201312.05). In conclusion, the Upper East Region demonstrates a high Hepatitis C antibody prevalence. Almost 60% of individuals have viremic infection, however the cost of RNA testing is a barrier to virological diagnosis. There is a need to educate the population about HCV-associated risk factors to reduce HCV transmission and burden of disease.<\/jats:p>","DOI":"10.1371\/journal.pone.0306292","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T17:25:30Z","timestamp":1719595530000},"page":"e0306292","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence and risk factors of Hepatitis C virus infection in the Upper East Region of Ghana; a community-based cross-sectional study"],"prefix":"10.1371","volume":"19","author":[{"given":"Ampem Darko Jnr","family":"Siaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Amugsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maame Adwoa Agyeman","family":"Owusu-Konadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Teye","family":"Drah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Gustav","family":"Imbeah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4223-4983","authenticated-orcid":true,"given":"Dominic","family":"Oduro-Donkor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8104-7393","authenticated-orcid":true,"given":"Amoako","family":"Duah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2891-3082","authenticated-orcid":true,"given":"Yvonne Ayerki","family":"Nartey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"issue":"34","key":"pone.0306292.ref001","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"A Petruzziello","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"8","key":"pone.0306292.ref002","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S2468-1253(22)00050-4","article-title":"Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review","volume":"7","author":"CJ Alberts","year":"2022","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"pone.0306292.ref003","unstructured":"World Health Organization. Hepatitis C. 2022 24 June 2022."},{"issue":"5","key":"pone.0306292.ref004","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","author":"S Blach","year":"2022","journal-title":"The Lancet Gastroenterology & Hepatology"},{"issue":"12","key":"pone.0306292.ref005","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S2468-1253(17)30249-2","article-title":"Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030","volume":"2","author":"MW Sonderup","year":"2017","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"pone.0306292.ref006","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis. World Health Organization; 2016."},{"key":"pone.0306292.ref007","unstructured":"Organization WH. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030. 2022."},{"key":"pone.0306292.ref008","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12879-016-1584-1","article-title":"A Synthesis of Hepatitis C prevalence estimates in Sub-Saharan Africa: 2000\u20132013","volume":"16","author":"N Mora","year":"2016","journal-title":"BMC Infect Dis"},{"key":"pone.0306292.ref009","article-title":"Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis","volume":"16","author":"Akosua Adom Agyeman","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"6","key":"pone.0306292.ref010","doi-asserted-by":"crossref","first-page":"e0287580","DOI":"10.1371\/journal.pone.0287580","article-title":"Hepatitis C virus seroprevalence, testing, and treatment capacity in public health facilities in Ghana, 2016\u20132021; A multi-centre cross-sectional study","volume":"18","author":"YA Nartey","year":"2023","journal-title":"Plos one"},{"issue":"1","key":"pone.0306292.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-020-01581-9","article-title":"Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index","volume":"20","author":"YA Nartey","year":"2020","journal-title":"BMC gastroenterology"},{"issue":"1","key":"pone.0306292.ref012","first-page":"1","article-title":"Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index","volume":"20","author":"Yvonne Ayerki Nartey","year":"2022","journal-title":"BMC Gastroenterology"},{"issue":"1","key":"pone.0306292.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-020-05937-5","article-title":"An assessment of hospital maternal health services in northern Ghana: a cross-sectional survey","volume":"20","author":"EK Ameyaw","year":"2020","journal-title":"BMC Health Services Research"},{"issue":"8","key":"pone.0306292.ref014","first-page":"14","article-title":"Poverty and Health Issues in the Northern Part of Ghana","volume":"9","author":"Y Xu","year":"2019","journal-title":"Poverty and Health Issues in the Northern Part of Ghana"},{"key":"pone.0306292.ref015","unstructured":"Tripmondo. Touring Sandema [https:\/\/www.tripmondo.com\/ghana\/upper-east-region\/sandema\/."},{"key":"pone.0306292.ref016","unstructured":"Cochran WG. Sampling techniques: John Wiley & Sons; 1977."},{"key":"pone.0306292.ref017","unstructured":"Nartey YA, Atsu SK, Awuku YA, Duah A, Agyei-Nkansah A, Gupta N, et. al. The Screening and Treatment Opportunity Project for Hepatitis C (STOP HepC) for HCV Elimination in Ghana: Progress on Initial Project Milestones. Conference on Liver Disease in Africa; 2023 7\u20139 September 2023; Dar Es Salaam, Tanzania."},{"key":"pone.0306292.ref018","unstructured":"Ghana Health Service. Ghana\u2019s Health Sector Launches A \u201cStop Hepatitis C Ghana Project\u201d. 2023. p. https:\/\/ghs.gov.gh\/2023\/03\/13\/ghanas-health-sector-launches-a-stop-hepatitis-c-ghana-project\/."},{"key":"pone.0306292.ref019","unstructured":"Guanghzhou Wondfo Biotech Co. Ltd. HCV Rapid Test. 2022."},{"issue":"7","key":"pone.0306292.ref020","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(15)00006-7","article-title":"Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis","volume":"15","author":"VB Rao","year":"2015","journal-title":"The Lancet infectious diseases"},{"issue":"1","key":"pone.0306292.ref021","article-title":"Hepatitis C virus (HCV) infection in Africa: a review","volume":"14","author":"MJ Karoney","year":"2013","journal-title":"Pan African medical journal"},{"issue":"1","key":"pone.0306292.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-1584-1","article-title":"A synthesis of hepatitis C prevalence estimates in Sub-Saharan Africa: 2000\u20132013","volume":"16","author":"N Mora","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"4","key":"pone.0306292.ref023","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/JLP.JLP_172_19","article-title":"Evaluation of screening effectiveness of hepatitis B surface antigen and anti-HCV rapid test kits in Pakistan","volume":"11","author":"U Waheed","year":"2019","journal-title":"J Lab Physicians"},{"issue":"7","key":"pone.0306292.ref024","doi-asserted-by":"crossref","first-page":"e0235036","DOI":"10.1371\/journal.pone.0235036","article-title":"Sensitivity and specificity of commercially available rapid diagnostic tests for viral hepatitis B and C screening in serum samples","volume":"15","author":"G Jargalsaikhan","year":"2020","journal-title":"PLoS One"},{"key":"pone.0306292.ref025","unstructured":"World Health Organization. Progress report on access to hepatitis C treatment: focus on overcoming barriers in low-and middle-income countries. World Health Organization; 2018."},{"key":"pone.0306292.ref026","article-title":"HCV Diagnosis in Ghana\u2014Limitations and Public Health Implications","author":"P. Owusu-Oduro","year":"2013","journal-title":"Texila International Journal Of Public Health"},{"issue":"1","key":"pone.0306292.ref027","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"E Gower","year":"2014","journal-title":"Journal of hepatology"},{"issue":"10","key":"pone.0306292.ref028","doi-asserted-by":"crossref","first-page":"e0187177","DOI":"10.1371\/journal.pone.0187177","article-title":"Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions","volume":"12","author":"M Harfouche","year":"2017","journal-title":"PloS one"},{"issue":"5","key":"pone.0306292.ref029","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","author":"S Blach","year":"2022","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"pone.0306292.ref030","unstructured":"Mwangi J, Nganga Z, Mpoke S, Lihana R, Kinyua J, Lagat N, et al. Hepatitis C virus genotypes in Kenya. (1432\u20138798 (Electronic))."},{"issue":"6","key":"pone.0306292.ref031","doi-asserted-by":"crossref","first-page":"e0287580","DOI":"10.1371\/journal.pone.0287580","article-title":"Hepatitis C virus seroprevalence, testing, and treatment capacity in public health facilities in Ghana, 2016\u20132021; A multi-centre cross-sectional study","volume":"18","author":"YA Nartey","year":"2023","journal-title":"PLoS One"},{"issue":"1, Part 3","key":"pone.0306292.ref032","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jfma.2019.07.011","article-title":"Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan","volume":"119","author":"JH Wang","year":"2020","journal-title":"Journal of the Formosan Medical Association"},{"issue":"5","key":"pone.0306292.ref033","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/M16-0065","article-title":"Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis","volume":"165","author":"JM Freiman","year":"2016","journal-title":"Annals of internal medicine"},{"issue":"14","key":"pone.0306292.ref034","first-page":"7914","article-title":"Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana","volume":"77","author":"D Candotti","year":"2003","journal-title":"West Africa. J Virol"},{"key":"pone.0306292.ref035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcv.2017.01.006","article-title":"Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection","volume":"88","author":"E Gupta","year":"2017","journal-title":"Journal of Clinical Virology"},{"issue":"1","key":"pone.0306292.ref036","first-page":"187","article-title":"Egypt\u2019s Ambitious Strategy to Eliminate Hepatitis C Virus: A Case Study","volume":"9","author":"H Ahmed","year":"2021","journal-title":"Global Health: Science and Practice"},{"key":"pone.0306292.ref037","unstructured":"Statement to the media on certification of Egypt reaching the gold tier on the Path to Elimination for HCV Cairo, Egypt\u2013 9 October 2023 [press release]. 9th October 2023 2023."},{"key":"pone.0306292.ref038","unstructured":"Meda N, Tuaillon E, Kania D, Tiendrebeogo A, Pisoni A, Zida S, et al. Hepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional study. (1564\u20130604 (Electronic))."},{"key":"pone.0306292.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-018-3983-4","article-title":"Hepatitis C virus infections and associated risk factors in patients with diabetes mellitus; case control study in North West Tigray, Ethiopia","volume":"11","author":"G Gebrekristos","year":"2018","journal-title":"BMC Research Notes"},{"issue":"4","key":"pone.0306292.ref040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13337-016-0345-5","article-title":"Risky exposures and national estimate of HCV seroprevalence among school children in urban Egypt","volume":"27","author":"EW Abd El-Wahab","year":"2016","journal-title":"Virusdisease"},{"key":"pone.0306292.ref041","doi-asserted-by":"crossref","first-page":"617480","DOI":"10.1155\/2013\/617480","article-title":"Female Genital Cutting and Hepatitis C Spread in Egypt","volume":"2013","author":"C Kenyon","year":"2013","journal-title":"ISRN Hepatol"},{"key":"pone.0306292.ref042","doi-asserted-by":"crossref","first-page":"6675579","DOI":"10.1155\/2021\/6675579","article-title":"Female Genital Mutilation in Ghana: Prevalence and Socioeconomic Predictors","volume":"2021","author":"AR Alhassan","year":"2021","journal-title":"BioMed Research International"},{"issue":"1","key":"pone.0306292.ref043","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12887-017-0937-2","article-title":"The influence of socioeconomic factors on choice of infant male circumcision provider in rural Ghana; a community level population based study","volume":"17","author":"T Gyan","year":"2017","journal-title":"BMC Pediatr"},{"key":"pone.0306292.ref044","unstructured":"Centers for Disease Control. HCV Infection Challenges 2023 [https:\/\/www.cdc.gov\/nchhstp\/pregnancy\/challenges\/hcv.html#:~:text=The%20risk%20of%20an%20HCV,or%20is%20coinfected%20with%20HIV.&text=There%20are%20currently%20no%20treatments,of%20HCV%20infection%20to%20infants."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0306292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T17:25:55Z","timestamp":1719595555000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0306292"}},"subtitle":[],"editor":[{"given":"Yury E","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0306292","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}